UnknownNCT06260982
Cognitive Disorders in Hereditary Spastic Paraplegia Type 4
Studying Autosomal dominant spastic paraplegia type 4
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Central Hospital, Nancy, France
- Principal Investigator
- Mathilde RenaudCentral Hospital Nancy
- Intervention
- 18-FDG-PET(radiation)
- Enrollment
- 30 enrolled
- Eligibility
- All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- Centre hospitalier régional universitaire, Nancy, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06260982 on ClinicalTrials.govOther trials for Autosomal dominant spastic paraplegia type 4
Additional recruiting or active studies for the same condition.
See all trials for Autosomal dominant spastic paraplegia type 4 →